| Financial Year |
September 30 2021 |
| Monetary Funds |
48,346,563.51 |
| Held-for-trading Financial Assets |
5,110,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,022,703,042.28 |
| Advances to Suppliers |
155,559,730.92 |
| Other Receivables |
1,673,929,007.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,517,258.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
71,265,530.02 |
| Total Current Assets |
4,071,164,944.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,779,242.31 |
| Investment Properties |
100,079,795.98 |
| Fixed Assetes |
1,263,534,741.69 |
| Under-construction Projects |
462,424,323.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
427,933,771.23 |
| R&D expenses |
-- |
| Goodwill |
132,679.93 |
| Long-Term Deferred and Prepaid Expenses |
1,867,975.93 |
| Deferred Income Tax Assets |
352,370,384.86 |
| Other Non-Current Assets |
67,313,497.51 |
| Sub-Total of Non-Current Assets |
2,684,214,301.22 |
| Total Assets |
6,755,379,245.75 |
| Short-Term Loans |
762,405,008.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,000,000.00 |
| Accounts Payable |
525,600,652.42 |
| Accounts Received In Advance |
112,091,795.48 |
| Employee Compensation Payable |
17,206,684.06 |
| Taxes Payable |
86,460,580.09 |
| Interest Payable |
108,259,579.73 |
| Dividend Payable |
1,333,277.33 |
| Other payables |
693,984,565.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
400,000,000.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,602,749,286.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
300,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
156,913,744.70 |
| Deferred Income Tax Liabilities |
18,419,646.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
182,118,094.22 |
| Total Liabilities |
2,784,867,380.31 |
| Paid-In Capital(Or Share Stock) |
594,146,206.93 |
| Capital Surplus |
2,589,618,161.57 |
| Surplus Reserve |
254,545,338.88 |
| LESS:Treasury Stock |
991,900.00 |
| Undistributed Profits |
352,750,048.15 |
| Minority Stockholder's Interest |
180,383,509.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,790,128,355.53 |
| Owner's Equity（Stockholder's Equity） |
3,970,511,865.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,755,379,245.75 |
